In vitro and in vivo cytotoxic effects of nitric oxide on metastatic cells

Cancer Letters

Volumn 115, Issue 1, 1997, Pages 57-62

  Hirano, Seishiro ^a  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

Author keywords

B16 melanoma; Inhalation; Lewis lung carcinoma; Metastasis; Nitric oxide

Indexed keywords

N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITROGEN DIOXIDE; OXYHEMOGLOBIN; SCAVENGER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEWIS CARCINOMA; MALE; MELANOMA B16; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ANIMALS; CARCINOMA, LEWIS LUNG; LUNG; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NITRIC OXIDE; ORGAN SIZE; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0031148564     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)04706-X     Document Type: Article

References (33)

1. [1] Stuehr, D.J. and Marletta, M.A. (1985) Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide, Proc. Natl. Acad. Sci. USA, 82, 7738-7742.
2. [2] Lavnikova, N., Drapier, J.-C. and Laskin, D.L. (1993) A single exogenous stimulus activates resident rat macrophages for nitric oxide production and tumor cytotoxicity, J. Leukoc. Biol., 54, 322-328.
3. [3] Hibbs, J.B. Jr., Vavrin, Z. and Taintor, R.R. (1987) L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells, J. Immunol., 138, 550-565.
4. [4] Stuehr, D.J. and Nathan, C.F. (1989) A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells, J. Exp. Med., 169, 1543-1555.
5. [5] Hibbs, J.B. Jr., Taintor, R.R., Vavrin, Z. and Rachlin, E.M. (1988) Nitric oxide: a cytotoxic activated macrophage effector molecule, Biochem. Biophys. Res. Commun., 157, 87-94.
6. [6] Kwon, N.S., Stuehr, D.J. and Nathan, C.F. (1991) Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide, J. Exp. Med., 174, 761-767.
7. [7] Lepoivre, M., Flaman, J.-M., Bobé, P., Lemaire, G. and Henry, Y. (1994) Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide, J. Biol. Chem., 269, 21891-21897.
8. [8] Lepoivre, M., Chenais, B., Yapo, A., Lemaire, G., Thelander, L. and Tenu, J.-P. (1990) Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells, J. Biol. Chem., 265, 14143-14149.
9. [9] Lepoivre, M., Fieschi, F., Coves, J., Thelander, L. and Fontecave, M. (1991) Inactivation of ribonucleotide reductase by nitric oxide, Biochem. Biophys. Res. Commun., 179, 442-448.
10. [10] Keller, R., Geiges, M. and Keist, R. (1990) L-Arginine-dependent reactive nitrogen intermediates as mediators of tumor cell killing by activated macrophages, Cancer Res., 50, 1421-1425.
11. [11] Hirano, S. (1996) Interaction of alveolar macrophages with pulmonary epithelial cells following exposure to lipopolysaccharide, Arch. Toxicol., 70, 230-236.
12. [12] Dong, Z., Staroselsky, A.H., Qi, X. and Fidler, I.J. (1994) Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells, Cancer Res., 54, 789-793.
13. [13] Ohshima, H. and Bartsch, H. (1994) Chronic infections and inflammatory processed as cancer risk factors: possible role of nitric oxide in carcinogenesis, Mutat. Res., 305, 253-264.
14. [14] Lowenstein, C.J. and Snyder, S.H. (1992) Nitric oxide: a novel biologic messenger, Cell, 70, 705-707.
15. [15] Zapol, W.M., Rimar, S., Gillis, N., Marletta, M. and Bosken, C.H. (1994) Nitric oxide and the lung, Am. J. Respir. Crit. Care Med., 149, 1375-1380.
16. [16] Pepke-Zaba, J., Higenbottam, T.W., Dinh-Xuan, A.T., Stone, D. and Wallwork, J. (1991) Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension, Lancet, 338, 1173-1174.
17. [17] Gustafsson, L.E. (1993) Experimental studies on nitric oxide, Scand. J. Work Environ. Health, 19 (Suppl. 2), 44-49.
18. [18] Adatia, I., MRCP (UK), FRCP (C) and Wessel, D.L. (1994) Therapeutic use of inhaled nitric oxide. Curr. Opin. Pediatr., 4, 583-590.
19. [19] Miller, O.I., Celermajer, D.S., Deanfield, J.E. and Macrae, D.J. (1994) Guidelines for the safe administration of inhaled nitric oxide, Arch. Dis. Child., 70, F47-F49.
20. [20] Guidot, D.M., Repine, M.J., Hybertson, B.M. and Repine, J.E. (1995) Inhaled nitric oxide prevents neutrophil-mediated, oxygen radical-dependent leak in isolated rat lungs, Am. J. Physiol., 269, L2-L5.
21. [21] Wink, D.A., Hanbauer, I., Laval, F., Cook, J.A., Krishna, M.C. and Mitchell, J.B. (1994) Nitric oxide protects against the cytotoxic effects of reactive oxygen species, Ann. N. Y. Acad. Sci., 738, 265-278.
22. [22] Radi, R., Beckman, J.S., Bush, K.M. and Freeman, B.A. (1991) Peroxynitrite oxidation of sulfhydryls, J. Biol. Chem., 266, 4244-4250.
23. [23] Freeman, B. Free radical chemistry of nitric oxides: looking at the dark side. Chest, 105, 79S-84S.
24. [24] Fidler, I.J. (1978) General considerations for studies of experimental cancer metastasis. In: Methods in Cancer Research, pp. 399-439. Editor: H. Busch. Academic Press, New York.
25. X, Am. Ind. Hyg. Assoc. J., 40, 588-591.
26. [26] Adatia, I., Thompson, J., Landzberg, M. and Wessel, D.L. (1993) Inhaled nitric oxide in chronic obstructive lung disease, Lancet, 341, 307-308.
27. [27] Oda, H., Kusumoto, S. and Nakajima, T. (1975) Nitrosyl-hemoglobin formation in the blood of animals exposed to nitric oxide, Arch. Environ. Health, 30, 453-455.
28. 2 on chronic bronchitics, Environ. Health Perspect., 29, 137-142.
29. [29] Sherwin, R.P. and Richters, V. (1982) Hypereplasia of Type 2 pneumocytes following 0.34 ppm nitrogen dioxide exposure: quantitation by image analysis, Arch. Environ. Health, 37, 306-315.
30. [30] Hayashi, Y., Kohno, T. and Ohwada, H. (1987) Morphological effects of nitrogen dioxide on the rat lung, Environ. Health Perspect., 73, 135-145.
31. [31] Gaston, B., Drazen, J.M., Loscalzo, J. and Stamler, J.S. (1994) The biology of nitrogen oxides in the airways, Am. J. Respir. Crit. Care Med., 149, 538-551.
32. [32] Kobayashi, T., Todoroki, T. and Sato, H. (1987) Enhancement of pulmonary metastasis of murine fibrosarcoma NR-FS by ozone exposure, J. Toxicol. Environ. Health, 20, 135-145.
33. [33] Norman, V. and Keith, C.H. (1965) Nitrogen oxides in tobacco smoke, Nature, 205, 915-916.